Citigroup Inc Protagonist Therapeutics, Inc Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Citigroup Inc holds 152,580 shares of PTGX stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,580

Previous 77,951 95.74%

Holding current value

$12.9 Million

Previous $4.31 Million 135.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$49.7 - $67.42 $3.71 Million - $5.03 Million	74,629 Added 95.74%	152,580 $10.1 Million
Q2 2025 Aug 11, 2025	SELL	$40.89 - $56.37 $1.79 Million - $2.47 Million	-43,893 Reduced 36.02%	77,951 $4.31 Million
Q1 2025 May 12, 2025	BUY	$35.09 - $59.76 $28,843 - $49,122	822 Added 0.68%	121,844 $5.89 Million
Q4 2024 Feb 12, 2025	BUY	$38.51 - $48.43 $1.83 Million - $2.3 Million	47,532 Added 64.68%	121,022 $4.67 Million
Q3 2024 Nov 12, 2024	BUY	$33.72 - $47.33 $1.77 Million - $2.48 Million	52,475 Added 249.7%	73,490 $3.3 Million

Q2 2024 Aug 12, 2024	SELL	$24.66 - $34.8 $4.63 Million - $6.53 Million	-187,626 Reduced 89.93%	21,015 $728,000
Q1 2024 May 10, 2024	BUY	$21.79 - $32.15 $2.96 Million - $4.37 Million	135,938 Added 186.98%	208,641 $6.04 Million
Q4 2023 Feb 09, 2024	SELL	$14.05 - $23.44 $1.06 Million - $1.76 Million	-75,125 Reduced 50.82%	72,703 $1.67 Million
Q3 2023 Nov 09, 2023	BUY	$16.68 - $23.66 $672,320 - $953,663	40,307 Added 37.49%	147,828 $2.47 Million
Q2 2023 Aug 10, 2023	SELL	$18.02 - $29.36 $1.53 Million - $2.49 Million	-84,828 Reduced 44.1%	107,521 $2.97 Million
Q1 2023 May 11, 2023	BUY	$10.78 - $25.38 $477,349 - $1.12 Million	44,281 Added 29.91%	192,349 $4.42 Million
Q4 2022 Feb 09, 2023	SELL	$7.36 - $11.17 $1.23 Million - $1.87 Million	-167,126 Reduced 53.02%	148,068 $1.62 Million
Q3 2022 Nov 10, 2022	SELL	$7.86 - $11.71 $18,117 - $26,991	-2,305 Reduced 0.73%	315,194 $2.66 Million
Q2 2022 Aug 10, 2022	BUY	$7.06 - $25.52 $1.99 Million - $7.19 Million	281,843 Added 790.45%	317,499 $2.51 Million
Q1 2022 May 12, 2022	SELL	$23.34 - $36.08 $2.38 Million - $3.68 Million	-102,095 Reduced 74.12%	35,656 $844,000
Q4 2021 Feb 10, 2022	BUY	$17.63 - $37.1 $1.53 Million - $3.21 Million	86,566 Added 169.12%	137,751 $4.71 Million
Q3 2021 Nov 10, 2021	BUY	$12.95 - $49.69 $662,845 - $2.54 Million	51,185 New	51,185 $907,000

Others Institutions Holding PTGX

# of Institutions

296

Shares Held

66.9M

Call Options Held

139K

Put Options Held

40.7K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $4.15B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account